vTv Therapeutics
Price & Volume
Stats
See more52W Range | $13.20-$44 |
Market Cap | $168.2M |
Shares Short | 16,694 |
Financials
See moreRevenue (12 Mos) | $17,000 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | -$16.1M |
Diluted EPS | -$3.30 |
News
See moreYahoo Finance • 21 days ago
vTv Therapeutics and M42’s IROS Announce Submission of Phase 2 Clinical Study Protocol for Cadisegliatin in Type 2 Diabetes to the United Arab Emirates Department of Health
Yahoo Finance • 2 months ago
vTv Therapeutics GAAP EPS of -$1.08 misses by $0.11
Yahoo Finance • 2 months ago
vTv Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update
Yahoo Finance • 3 months ago
vTv Therapeutics Announces New Appointments to its Scientific Advisory Board
About
CEO | Mr. Paul J. Sekhri M.Sc. |
CFO | Dr. Michael Steven Tung M.B.A., M.D. |
Address | 3980 Premier Drive, High Point, NC, United States, 27265 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 23 |
